Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ac-eemqrr-nh2
2. Acetyl Hexapeptide-8
3. Acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide
1. 616204-22-9
2. Acetyl Hexapeptide
3. Argireline Acetate
4. Argireline Acetate Anti-aging Cosmetic Peptide
5. Schembl223824
6. (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-5-oxopentanoic Acid
7. (6s,9s,12s,15s,18s,21s)-21-acetamido-1-amino-12-(3-amino-3-oxopropyl)-6-carbamoyl-18-(2-carboxyethyl)-9-(3-guanidinopropyl)-1-imino-15-(2-(methylthio)ethyl)-8,11,14,17,20-pentaoxo-2,7,10,13,16,19-hexaazatetracosan-24-oic Acid
8. N-acetyl-l-alpha-glutamyl-l-alpha-glutamyl-l-methionyl-l-glutaminyl-l-arginyl-l-argininamide
9. Schembl22265244
10. Argireline(acetyl Hexapeptide-3)
11. Molport-009-194-173
12. Amy25367
13. Ex-a6258
14. Hy-p0033
15. Ac8712
16. Akos015994631
17. Zinc169719042
18. Cs-5101
19. Hs-2002
20. Ac-28736
21. 204a229
22. A868667
23. J-700142
24. Q-200583
25. Ac-glu-glu-met-glu-arg-arg-nh2;n-acetyl-l-alpha-glutamyl-l-alpha-glutamyl-l-methionyl-l-glutaminyl-l-arginyl-l-argininamide
Molecular Weight | 889.0 g/mol |
---|---|
Molecular Formula | C34H60N14O12S |
XLogP3 | -6.3 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 32 |
Exact Mass | 888.42358458 g/mol |
Monoisotopic Mass | 888.42358458 g/mol |
Topological Polar Surface Area | 490 Ų |
Heavy Atom Count | 61 |
Formal Charge | 0 |
Complexity | 1610 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Argireline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Argireline, including repackagers and relabelers. The FDA regulates Argireline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Argireline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Argireline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Argireline supplier is an individual or a company that provides Argireline active pharmaceutical ingredient (API) or Argireline finished formulations upon request. The Argireline suppliers may include Argireline API manufacturers, exporters, distributors and traders.
click here to find a list of Argireline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Argireline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Argireline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Argireline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Argireline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Argireline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Argireline suppliers with NDC on PharmaCompass.
Argireline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Argireline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Argireline GMP manufacturer or Argireline GMP API supplier for your needs.
A Argireline CoA (Certificate of Analysis) is a formal document that attests to Argireline's compliance with Argireline specifications and serves as a tool for batch-level quality control.
Argireline CoA mostly includes findings from lab analyses of a specific batch. For each Argireline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Argireline may be tested according to a variety of international standards, such as European Pharmacopoeia (Argireline EP), Argireline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Argireline USP).
LOOKING FOR A SUPPLIER?